Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
The following blood, urine and faecal samples will be collected, and assessments performed, at specified time points
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Subjects will receive a single administration of 14C Epaminurad Oral Solution | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 14C Epaminurad Oral Solution | Drug | Subjects will receive a single administration of 14C Epaminurad Oral Solution |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mass balance recovery of total radioactivity in all excreta (urine and faeces) | Collection of plasma, urine and faeces samples during time frame point | Baseline to Day 8 |
| Metabolite profling and structural identification | Collection of plasma, urine and faeces samples during time frame point | Baseline to Day 8 |
Not provided
Not provided
Inclusion Criteria:
1. Healthy volunteers
Exclusion Criteria:
1. Subjects does not meet the Inclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| McKenzie Litza, Principal Investigator | Quotient Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Quotient Science | Nottingham | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided